Vierhapper H, Laggner A, Waldhäusl W, Grubeck-Loebenstein B, Kleinberger G
Acta Endocrinol (Copenh). 1982 Dec;101(4):542-9. doi: 10.1530/acta.0.1010542.
Thyroid and pituitary function was studied in 10 male and 6 patients female during critical non-endocrine disease. Low concentrations of TT3 were observed in each case. Seven patients out of whom 3 survived, presented with low levels of TT4 due to deficiency in TBG in the presence of normal values of FTI and FT4, whereas a 'low T4-syndrome', characterized by low concentrations of both TT4 and FT4 was seen in 9 patients, 8 of whom died 1 to 16 days after evaluation of pituitary function. A diminished response of TSH to iv TRH (400 micrograms), as observed in 4 patients with normal FT4 and in all patients with 'low T4-syndrome', was not accompanied by a concomitant lack in stimulated release of LH, FSH and Pr1 in the majority of cases. However, the secretory maximum of LH and FSH following stimulation by LRH (100 micrograms iv) was delayed in 10 and in 9 patients, respectively, including patients both with normal and subnormal concentrations of FT4. From the above it appears that low stimulated concentrations of TSH in the presence of subnormal concentrations of FT4 indicate an extremely poor prognosis in critically ill patients. The abnormal behaviour of TSH in this group of patients cannot be explained by generalized pituitary insufficiency or by an increase in FT4.
对10名男性和6名女性危重症非内分泌疾病患者的甲状腺和垂体功能进行了研究。在每个病例中均观察到TT3浓度较低。7例患者(其中3例存活)由于TBG缺乏,在FTI和FT4值正常的情况下出现TT4水平较低,而9例患者出现了以TT4和FT4浓度均较低为特征的“低T4综合征”,其中8例在垂体功能评估后1至16天死亡。在4例FT4正常的患者以及所有“低T4综合征”患者中观察到TSH对静脉注射TRH(400微克)的反应减弱,但在大多数情况下,LH、FSH和Pr1的刺激释放并未同时缺乏。然而,LRH(静脉注射100微克)刺激后LH和FSH的分泌峰值分别在10例和9例患者中延迟,包括FT4浓度正常和低于正常的患者。由此可见,在FT4浓度低于正常的情况下,TSH刺激浓度较低表明危重症患者预后极差。该组患者中TSH的异常表现无法用全身性垂体功能不全或FT4升高来解释。